Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for priority review the supplemental biologics license application for ...
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...
The oversubscribed series B financing was co-led by EQT Life Sciences and Sanofi Ventures, according to a Jan. 28 release. Existing investor F-Prime Capital also joined the round, with ...
Patients to pay no more than $35 a month Eli Lilly, Sanofi previously settled overcharging claims Novo Nordisk denies wrongdoing, pledges affordable insulin Jan 27 (Reuters) - Novo Nordisk (NOVOb ...
HealthDay News — The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current Good Manufacturing Practice for active pharmaceutical ...
(HealthDay News) — The US Food and Drug Administration (FDA) has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ...
Also Read: Sanofi’s Blood Cancer Drug’s New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma The facility’s quality unit was also scrutinized for its inability to ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan ...
The US Food and Drug Administration has issued a warning letter to French drugmaker Sanofi (Euronext: SAN) following an inspection of its Massachusetts manufacturing site. The missive raises concerns ...
A new FDA warning letter for French pharmaceutical company Sanofi cited a handful of issues at its biologics factory in Massachusetts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback